Chargement en cours...
High‐throughput compound screen reveals mTOR inhibitors as potential therapeutics to reduce (auto)antibody production by human plasma cells
Antibody production by the B cell compartment is a crucial part of the adaptive immune response. Dysregulated antibody production in the form of autoantibodies can cause autoimmune disease. To date, B‐cell depletion with anti‐CD20 antibodies is commonly applied in autoimmunity, but pre‐existing plas...
Enregistré dans:
| Publié dans: | Eur J Immunol |
|---|---|
| Auteurs principaux: | , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6972998/ https://ncbi.nlm.nih.gov/pubmed/31621069 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/eji.201948241 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|